Your Basket 0

Filter

Applications Product Type Company
<<First <Prev    Next> Last>>
Search Results for:
Catalogue No Partner Description Species Application
HY-101664-10mg MedChemexpress LLC Ilaprazole [CAS 172152-36-2] Cancer-programmed cell death
HY-101664-100mg MedChemexpress LLC Ilaprazole [CAS 172152-36-2] Cancer-programmed cell death
HY-101664-2mg MedChemexpress LLC Ilaprazole [CAS 172152-36-2] Cancer-programmed cell death
HY-101664-5mg MedChemexpress LLC Ilaprazole [CAS 172152-36-2] Cancer-programmed cell death
HY-101664-50mg MedChemexpress LLC Ilaprazole [CAS 172152-36-2] Cancer-programmed cell death
HY-102001-10mg MedChemexpress LLC Tomaymycin DM [CAS 945490-09-5] Cancer-programmed cell death
HY-102001-25mg MedChemexpress LLC Tomaymycin DM [CAS 945490-09-5] Cancer-programmed cell death
HY-102001-5mg MedChemexpress LLC Tomaymycin DM [CAS 945490-09-5] Cancer-programmed cell death
HY-102001-50mg MedChemexpress LLC Tomaymycin DM [CAS 945490-09-5] Cancer-programmed cell death
HY-106662-10mg MedChemexpress LLC Chloroquinoxaline sulfonamide [CAS 97919-22-7] Cancer-programmed cell death
HY-106662-100mg MedChemexpress LLC Chloroquinoxaline sulfonamide [CAS 97919-22-7] Cancer-programmed cell death
HY-106662-25mg MedChemexpress LLC Chloroquinoxaline sulfonamide [CAS 97919-22-7] Cancer-programmed cell death
HY-106662-5mg MedChemexpress LLC Chloroquinoxaline sulfonamide [CAS 97919-22-7] Cancer-programmed cell death
HY-106662-50mg MedChemexpress LLC Chloroquinoxaline sulfonamide [CAS 97919-22-7] Cancer-programmed cell death
HY-108730-1mg MedChemexpress LLC Avelumab [CAS 1537032-82-8] Cancer-programmed cell death
HY-108730-10mg MedChemexpress LLC Avelumab [CAS 1537032-82-8] Cancer-programmed cell death
HY-108730-25mg MedChemexpress LLC Avelumab [CAS 1537032-82-8] Cancer-programmed cell death
HY-108730-5mg MedChemexpress LLC Avelumab [CAS 1537032-82-8] Cancer-programmed cell death
HY-108730A-1mg MedChemexpress LLC Avelumab (anti-PD-L1) [CAS 1537032-82-8]
HY-108730A-10mg MedChemexpress LLC Avelumab (anti-PD-L1) [CAS 1537032-82-8]
HY-108730A-5mg MedChemexpress LLC Avelumab (anti-PD-L1) [CAS 1537032-82-8]
HY-108831-10mg MedChemexpress LLC Natalizumab [CAS 189261-10-7] COVID-19-immunoregulation
HY-108831-25mg MedChemexpress LLC Natalizumab [CAS 189261-10-7] COVID-19-immunoregulation
HY-108831-5mg MedChemexpress LLC Natalizumab [CAS 189261-10-7] COVID-19-immunoregulation
HY-108831A-1mg MedChemexpress LLC Natalizumab (Solution) [CAS 189261-10-7]
Address

Insight Biotechnology Limited
PO Box 520
Wembley
Middlesex
HA9 7YN
UK

Contact Us

Tel: 0800 073 3133 (UK)
Fax: 0800 953 0268 (UK)
Tel: +44 20 8385 0303 (International)
Email: Info@insightbio.com

Opening Hours

Monday to Friday- 9am- 5pm

Stay Connected!

@InsightBio

Quick Links

About Us>
Contact Us>
FAQs>
Partners>
Special Offers>
Technical Support>

Created by Purplesheep Internet Limited 2024. © Insight biotechnology. All rights reserved.